Fox Run Management L.L.C. acquired a new position in Envista Holdings Corporation (NYSE:NVST – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 43,215 shares of the company’s stock, valued at approximately $880,000.
Several other institutional investors and hedge funds also recently bought and sold shares of NVST. Farther Finance Advisors LLC lifted its position in shares of Envista by 317.6% in the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock worth $27,000 after purchasing an additional 1,026 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after buying an additional 949 shares during the period. SJS Investment Consulting Inc. grew its holdings in shares of Envista by 10,356.5% during the 3rd quarter. SJS Investment Consulting Inc. now owns 2,405 shares of the company’s stock valued at $49,000 after acquiring an additional 2,382 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of Envista by 378.0% in the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock worth $47,000 after acquiring an additional 1,909 shares during the last quarter. Finally, GAMMA Investing LLC raised its holdings in shares of Envista by 34.3% during the third quarter. GAMMA Investing LLC now owns 2,498 shares of the company’s stock worth $51,000 after acquiring an additional 638 shares in the last quarter.
Envista Stock Down 0.9%
NVST stock opened at $29.31 on Friday. The stock has a market capitalization of $4.80 billion, a price-to-earnings ratio of 104.68, a price-to-earnings-growth ratio of 2.03 and a beta of 1.01. The company has a 50-day moving average of $25.03 and a two-hundred day moving average of $22.10. Envista Holdings Corporation has a 52-week low of $14.22 and a 52-week high of $30.42. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.38 and a quick ratio of 2.04.
Analyst Upgrades and Downgrades
NVST has been the topic of a number of recent research reports. Mizuho boosted their target price on Envista from $24.00 to $27.00 and gave the company a “neutral” rating in a research note on Tuesday, February 10th. Leerink Partners set a $35.00 price target on Envista and gave the company an “outperform” rating in a research note on Friday, February 6th. JPMorgan Chase & Co. increased their price objective on Envista from $22.00 to $26.00 and gave the stock a “neutral” rating in a report on Friday, February 6th. Evercore restated an “outperform” rating and set a $32.00 price target on shares of Envista in a research note on Friday, February 6th. Finally, Wells Fargo & Company lifted their price objective on shares of Envista from $21.00 to $26.00 and gave the company an “equal weight” rating in a research note on Friday, February 6th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Envista presently has an average rating of “Moderate Buy” and an average price target of $27.08.
View Our Latest Stock Analysis on Envista
Insider Activity
In related news, SVP Mischa Reis sold 9,675 shares of the business’s stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total transaction of $290,250.00. Following the transaction, the senior vice president owned 32,382 shares of the company’s stock, valued at approximately $971,460. The trade was a 23.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.66% of the company’s stock.
Envista Company Profile
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
See Also
- Five stocks we like better than Envista
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
